Cargando…

Drug-Repositioning Approaches Based on Medical and Life Science Databases

Drug repositioning is a drug discovery strategy in which an existing drug is utilized as a therapeutic agent for a different disease. As information regarding the safety, pharmacokinetics, and formulation of existing drugs is already available, the cost and time required for drug development is redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamami, Yoshito, Hamano, Hirofumi, Niimura, Takahiro, Aizawa, Fuka, Yagi, Kenta, Goda, Mitsuhiro, Izawa-Ishizawa, Yuki, Ishizawa, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591243/
https://www.ncbi.nlm.nih.gov/pubmed/34790124
http://dx.doi.org/10.3389/fphar.2021.752174
_version_ 1784599184425353216
author Zamami, Yoshito
Hamano, Hirofumi
Niimura, Takahiro
Aizawa, Fuka
Yagi, Kenta
Goda, Mitsuhiro
Izawa-Ishizawa, Yuki
Ishizawa, Keisuke
author_facet Zamami, Yoshito
Hamano, Hirofumi
Niimura, Takahiro
Aizawa, Fuka
Yagi, Kenta
Goda, Mitsuhiro
Izawa-Ishizawa, Yuki
Ishizawa, Keisuke
author_sort Zamami, Yoshito
collection PubMed
description Drug repositioning is a drug discovery strategy in which an existing drug is utilized as a therapeutic agent for a different disease. As information regarding the safety, pharmacokinetics, and formulation of existing drugs is already available, the cost and time required for drug development is reduced. Conventional drug repositioning has been dominated by a method involving the search for candidate drugs that act on the target molecules of an organism in a diseased state through basic research. However, recently, information hosted on medical information and life science databases have been used in translational research to bridge the gap between basic research in drug repositioning and clinical application. Here, we review an example of drug repositioning wherein candidate drugs were found and their mechanisms of action against a novel therapeutic target were identified via a basic research method that combines the findings retrieved from various medical and life science databases.
format Online
Article
Text
id pubmed-8591243
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85912432021-11-16 Drug-Repositioning Approaches Based on Medical and Life Science Databases Zamami, Yoshito Hamano, Hirofumi Niimura, Takahiro Aizawa, Fuka Yagi, Kenta Goda, Mitsuhiro Izawa-Ishizawa, Yuki Ishizawa, Keisuke Front Pharmacol Pharmacology Drug repositioning is a drug discovery strategy in which an existing drug is utilized as a therapeutic agent for a different disease. As information regarding the safety, pharmacokinetics, and formulation of existing drugs is already available, the cost and time required for drug development is reduced. Conventional drug repositioning has been dominated by a method involving the search for candidate drugs that act on the target molecules of an organism in a diseased state through basic research. However, recently, information hosted on medical information and life science databases have been used in translational research to bridge the gap between basic research in drug repositioning and clinical application. Here, we review an example of drug repositioning wherein candidate drugs were found and their mechanisms of action against a novel therapeutic target were identified via a basic research method that combines the findings retrieved from various medical and life science databases. Frontiers Media S.A. 2021-11-01 /pmc/articles/PMC8591243/ /pubmed/34790124 http://dx.doi.org/10.3389/fphar.2021.752174 Text en Copyright © 2021 Zamami, Hamano, Niimura, Aizawa, Yagi, Goda, Izawa-Ishizawa and Ishizawa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zamami, Yoshito
Hamano, Hirofumi
Niimura, Takahiro
Aizawa, Fuka
Yagi, Kenta
Goda, Mitsuhiro
Izawa-Ishizawa, Yuki
Ishizawa, Keisuke
Drug-Repositioning Approaches Based on Medical and Life Science Databases
title Drug-Repositioning Approaches Based on Medical and Life Science Databases
title_full Drug-Repositioning Approaches Based on Medical and Life Science Databases
title_fullStr Drug-Repositioning Approaches Based on Medical and Life Science Databases
title_full_unstemmed Drug-Repositioning Approaches Based on Medical and Life Science Databases
title_short Drug-Repositioning Approaches Based on Medical and Life Science Databases
title_sort drug-repositioning approaches based on medical and life science databases
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591243/
https://www.ncbi.nlm.nih.gov/pubmed/34790124
http://dx.doi.org/10.3389/fphar.2021.752174
work_keys_str_mv AT zamamiyoshito drugrepositioningapproachesbasedonmedicalandlifesciencedatabases
AT hamanohirofumi drugrepositioningapproachesbasedonmedicalandlifesciencedatabases
AT niimuratakahiro drugrepositioningapproachesbasedonmedicalandlifesciencedatabases
AT aizawafuka drugrepositioningapproachesbasedonmedicalandlifesciencedatabases
AT yagikenta drugrepositioningapproachesbasedonmedicalandlifesciencedatabases
AT godamitsuhiro drugrepositioningapproachesbasedonmedicalandlifesciencedatabases
AT izawaishizawayuki drugrepositioningapproachesbasedonmedicalandlifesciencedatabases
AT ishizawakeisuke drugrepositioningapproachesbasedonmedicalandlifesciencedatabases